Infectious Disease
Recent news:
The San Francisco Business Times examines crucial work by Dan Fletcher, Melanie Ott and Jennifer Doudna to create an efficient, smartphone-based CRISPR-cellscope hybrid COVID-19 test.
Adam Arkin’s lab is leading research to harness tailocins – protein machines made by bacteria that are able to target and attack very specific strains of bacteria. They hope to understand and use these natural spring-powered microneedles to study the microbiome, and eventually to attack and treat harmful infections.
Former BioE postdoc Kiana Aran, now a professor at KGI, along with Professor Irina Conboy and other collaborators, have demonstrated new disease-detection capabilities of a hand-held device based on CRISPR gene editing technology, a development that could lead to faster, portable genetic testing for diagnostics and research.
Professor Liana Lareau has been co-leading the Innovative Genomics Institute effort to monitor mutations in the SARS-CoV-2 virus in the local community. The team’s rapid sequencing turnaround is crucial for tracking the spread of new variants, including the more infectious B.1.1.7 recently detected in two cases at Berkeley.
Check out this video interview with Professor Dan Fletcher on his collaboration with CRISPR researchers to produce a rapid COVID-19 test using a smartphone camera.
- « Previous
- 1
- 2